Form 4: Rockwell Medical SVP, Chief Commercial Officer Timothy Chole Reports Stock Sale
SEC Form 4 Filing
Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, reports the sale of 1,001 shares of common stock on October 1, 2024, under a pre-arranged trading plan.
Summary
- On October 1, 2024, Timothy Chole, the SVP, Chief Commercial Officer of Rockwell Medical, sold 1,001 shares of common stock at a weighted average price of $3.6852 per share.
- The sale was executed under a Rule 10b5-1 trading plan adopted on June 7, 2024.
- Following the transaction, Chole beneficially owns 55,171 shares of Rockwell Medical common stock.
- An administrative error in a previous Form 3 filing on May 30, 2024, omitted the withholding of 2,823 shares for estimated tax obligations; this Form 4 corrects that error.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure related to insider trading activities, which are common and regulated in publicly traded companies. The sale was executed under a pre-arranged trading plan, which is a common practice to avoid accusations of trading on inside information.
Stakeholder Impact
- The stock sale by an officer could have a minor impact on shareholder sentiment, but the existence of a pre-arranged trading plan mitigates concerns about insider information being used.
Key Dates
| Date | Description |
|---|---|
| May 30, 2024 | Date of original Form 3 filing with an administrative error. |
| June 7, 2024 | Date the Rule 10b5-1 trading plan was adopted. |
| October 1, 2024 | Date of the stock sale transaction. |
| October 2, 2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.